Mostra el registre parcial de l'element

dc.contributor.authorMora, Toni
dc.contributor.authorJacobs, Rowena
dc.contributor.authorCid, Jordi
dc.contributor.authorRoche, David
dc.date.accessioned2025-03-12T10:33:29Z
dc.date.available2025-03-12T10:33:29Z
dc.date.issued2025
dc.identifier.citationMora, Toni; Jacobs, Rowena; Cid, Jordi [et al.]. Risky behaviours and injuries amongst Catalan children with ADHD: does pharmacological treatment improve outcomes? Health Economics Review, 2025, 15, 7. Disponible en: <https://healtheconomicsreview.biomedcentral.com/articles/10.1186/s13561-025-00595-x>. Fecha de acceso 12 mar. 2025. DOI: 10.1186/s13561-025-00595-xca
dc.identifier.issn2191-1991ca
dc.identifier.urihttp://hdl.handle.net/20.500.12328/4828
dc.descriptionTM and DR gratefully acknowledge the financial support from the Ministry of Science and Innovation grant PID2021-124067OB-C21.
dc.description.abstractBackground: Attention-Deficit/Hyperactivity Disorder (ADHD) prevalence rates are around 5–10% of school-aged children. We test whether medication use for ADHD decreases the likelihood of risky behaviour (sexual behaviour, alcohol, tobacco, and drug consumption) and injuries amongst children aged 6–18. Methods: We use a large administrative dataset for the whole population of Catalan children in Spain who were born between 1998 and 2012. We apply a scale that contains alternative definitions of ADHD so that over-diagnosis is also identified and estimate a count data model to explain the number of visits whilst accounting for confounding. Our identification strategy relies on instrumenting medication using an average indicator of the probability of prescribing medication for each most visited healthcare centre provider. Results: Our results suggest that medication use significantly reduced the number of visits of children diagnosed with ADHD for injuries but not risky behaviour. This finding is robust irrespective of the considered span or the grace period after including ADHD-related comorbidities as controls. Conclusion: In line with previous literature, medication use amongst children with ADHD reduces the prevalence of injuries but not risky behaviours.ca
dc.format.extent11ca
dc.language.isoengca
dc.publisherSpringer Natureca
dc.relation.ispartofHealth Economics Reviewca
dc.relation.ispartofseries15
dc.rightsThis article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.ca
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/.
dc.subject.otherConducta de riscca
dc.subject.otherLesionsca
dc.subject.otherTractament farmacològicca
dc.subject.otherTDAHca
dc.subject.otherDiagnòsticca
dc.subject.otherResultats de salutca
dc.subject.otherConducta de riesgoca
dc.subject.otherLesionesca
dc.subject.otherTratamiento farmacológicoca
dc.subject.otherTDAHca
dc.subject.otherDiagnósticoca
dc.subject.otherResultados de saludca
dc.subject.otherRisky behaviourca
dc.subject.otherInjuriesca
dc.subject.otherPharmacological treatmentca
dc.subject.otherADHDca
dc.subject.otherDiagnosisca
dc.subject.otherHealth outcomesca
dc.titleRisky behaviours and injuries amongst Catalan children with ADHD: does pharmacological treatment improve outcomes?ca
dc.typeinfo:eu-repo/semantics/articleca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/3PE/PID2021-124067OB-C21
dc.subject.udc33ca
dc.identifier.doihttps://dx.doi.org/10.1186/s13561-025-00595-xca


Fitxers en aquest element

 

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com http://creativecommons.org/licenses/by-nc-nd/4.0/.
Comparteix a TwitterComparteix a LinkedinComparteix a FacebookComparteix a TelegramComparteix a WhatsappImprimeix